Document is current
Any future updates will be listed below
-
Authors
Tostanoski, Lisa H. http://orcid.org/0000-0001-9255-5684
Chandrashekar, Abishek http://orcid.org/0000-0001-7821-5552
Patel, Shivani http://orcid.org/0000-0003-3475-1016
Yu, Jingyou
Jacob-Dolan, Catherine http://orcid.org/0000-0001-6641-0342
Chang, Aiquan
Powers, Olivia C.
Sellers, Daniel
Gardner, Sarah
Barrett, Julia
Sanborn, Owen
Stephenson, Kathryn E.
Ansel, Jessica L.
Jaegle, Kate
Seaman, Michael S.
Porto, Maciel http://orcid.org/0000-0002-3427-454X
Lok, Megan
Spence, Brittany
Cayer, Kathleen
Nase, Danielle
Holman, Shaikim
Bradette, Heath
Kar, Swagata
Andersen, Hanne http://orcid.org/0000-0003-1103-9608
Lewis, Mark G. http://orcid.org/0000-0001-7852-0135
Cox, Freek
Tolboom, Jeroen T. B. M.
de Groot, Anne Marit
Heerwegh, Dirk
Le Gars, Mathieu
Sadoff, Jerald
Wegmann, Frank http://orcid.org/0000-0002-9821-1492
Zahn, Roland C. http://orcid.org/0000-0003-2822-6231
Schuitemaker, Hanneke http://orcid.org/0000-0001-8563-2266
Barouch, Dan H. http://orcid.org/0000-0001-5127-4659
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA260476)
Janssen Research and Development
U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority (HHS0100201700018C)
Ragon Institute of MGH, MIT and Harvard
- License Information
-
More Information
Article History
Received: 4 October 2021
Accepted: 14 December 2021
First Online: 10 January 2022
Competing interests
: D.H.B., R.C.Z., F.W. and H.S. are co-inventors on provisional vaccine patents (63/121,482; 63/133,969; 63/135,182). F.C., J.T.B.M.T., A.Md.G., D.H., M.L.G., J.S., F.W., R.C.Z., H.S. are employees of Janssen Vaccines & Prevention BV and may hold stock in Johnson & Johnson.
